ETFChannel.com
CRL Description — Charles River Laboratories International Inc.

Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments are: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; and Manufacturing Support, which ensures the production and release of products manufactured by Co.'s clients.

Company Name: 
Charles River Laboratories International Inc.
Website: 
www.criver.com
Sector: 
Biotechnology
Number of ETFs Holding CRL: 
64
Total Market Value Held by ETFs: 
$1,475,859,494
Total Market Capitalization: 
$8,891,000,000
% of Market Cap. Held by ETFs: 
16.60%
 ETF   CRL Weight   CRL Amount 
 VTI   0.03%   $257,050,588         
 IJH   0.56%   $240,634,994         
 VB   0.25%   $226,800,853         
 VXF   0.18%   $124,799,318         
 MDY   0.56%   $80,747,533         
 FBT   3.79%   $78,606,930         
 VBR   0.25%   $69,372,575         
 VBK   0.26%   $64,786,593         
 IJK   1.00%   $62,338,704         
 IWP   0.26%   $31,892,657         
List of all 64 ETFs holding CRL »
Quotes delayed 20 minutes

Strong Buy (3.50 out of 4)
66th percentile
(ranked higher than approx. 66% of all stocks covered)

Analysts Forecast:
CRL Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding CRL | Charles River Laboratories International Inc. | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2020, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.